Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOMERICA INCBMRA · Entity 8171 | Chief Financial Officer | December 09, 2021 | December 10, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOMERICA INC
Report date December 09, 2021 · Filed December 10, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-qualified stock optionSEC Table II · derivative / convertible security · Conversion / exercise price $4.46 · Expires 2031-12-09 | Direct | 115,000 |
Reported balance
After 2021-12-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-12-09 · Grant · Acquired 40,000 · Balance 115,000 F2: Not applicable F1: 25% exercisable 12/9/2022, 25% per year exercisable there after. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% exercisable 12/9/2022, 25% per year exercisable there after.
F2: Not applicable
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2021 Filed Dec 10, 2021 23:18 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon-qualified stock option · Derivative | 40,000 | Not disclosed Strike: $4.46 | Not disclosed |
DisclosureSEC source: 0001513162-21-000149 · primary_doc.xml · derivative · entry 1 Sloan Steven · CIK 0001822874 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 40,000 shares Expires 2031-12-09 F2 · price: Not applicable F1 · derivative.exercise_date: 25% exercisable 12/9/2022, 25% per year exercisable there after. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 23:50 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon-qualified stock option · Derivative | 25,000 | Not disclosed Strike: $6.36 | Not disclosed |
DisclosureSEC source: 0001513162-20-000235 · primary_doc.xml · derivative · entry 1 Sloan Steven · CIK 0001822874 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 25,000 shares Expires 2030-12-10 F2 · price: Not applicable F1 · derivative.exercise_date: 25% exercisable 12/10/2021, 25% per year exercisable there after. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.